Corrigendum to “The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII” [Mol Genet Metab 2020 Mar;129(3):219–227]

Publication date: Available online 23 August 2020Source: Molecular Genetics and MetabolismAuthor(s): Raymond Y. Wang, José Francisco da Silva Franco, Jaime López-Valdez, Esmeralda Martins, Vernon Reid Sutton, Chester B. Whitley, Lin Zhang, Tricia Cimms, Deborah Marsden, Agnieszka Jurecka, Paul Harmatz

Source: Molecular Genetics and Metabolism - August 23, 2020 Category: Genetics & Stem Cells Source Type: research